Clinical Trial Update: Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting safety and long-term (up to 5 years) outcomes after a first booster dose of Novartis' Tick-borne encephalitis vaccine in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Novartis Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Tick Born Encephalitis | Phase 4 | Status: COMPLETED